Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With: autoimmune

  • Vitamin D and Marine n-3 Fatty Acids Reduce Autoimmune Diseases

    Continued use of vitamin D3 and n-3 fatty acids reduced the incidence of autoimmune diseases such as psoriasis.

  • The Paramedic’s Tale: From Agony to Activist

    In March 2020, Karyn Bishof, BS, had the physical strength and mental wherewithal to be a paramedic at a fire department. Through the close encounters and hands-on care required for the job, Bishof was infected with SARS-CoV-2. Shortly thereafter began the chronic syndromes and the array of neurological and physical conditions collectively called long COVID. Despite her limitations, Bishof founded the COVID-19 Longhauler Advocacy Project and began getting information out to others.

  • Threat of Reinfection Includes Long COVID

    Accumulating research suggests reinfections with SARS-CoV-2 increase the likelihood of developing long COVID, the horrific post-acute syndrome with indefinite duration and a panoply of neurological, autoimmune, and physical conditions. Moreover, the risk of developing long COVID incrementally increases with each reinfection, according to a study that found this cumulative effect continues in up to three reinfections.

  • Misdiagnosis of Autoimmune Encephalitis

    A recent multicenter, retrospective review of 393 adult patients given a diagnosis of autoimmune encephalitis noted that 107 patients (27%) were misdiagnosed and ultimately had other diagnoses confirmed, but after a considerable delay.

  • Magnetic Resonance Imaging Evaluation of Perivascular Space Abnormalities in Neuromyelitis Optica

    Perivascular space (PVS) abnormalities were demonstrated in two cohorts of patients with neuromyelitis optica spectrum disorder (NMOSD) as compared to healthy controls. Magnetic resonance imaging provided visualization of PVS enlargement, and quantification of reduced flow in NMOSD patients, both of which were found to be associated with disease outcomes.

  • COVID-19 Vaccination in Patients with Autoimmune Neuromuscular Diseases

    In a population-based, self-reporting survey of patients with immune-mediated myopathy and myasthenia gravis, the frequency of both mild and severe acute adverse events appeared to be no more frequent than in the general population. COVID-19 vaccinations are safe for this population of patients.

  • Evaluation and Treatment of Adrenal Insufficiency in the Emergency Department

    This article addresses the pathophysiology, discusses various clinical presentations, and reviews current evidence-based practices for managing adrenal insufficiency and crisis in the emergency department.

  • PANDAS: Examining the Evidence for Treatment Options

    Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) is a proposed disorder first named in 1998 that has been the subject of controversy in the literature. Although the debate has waned somewhat in the United States, it remains a topic of discussion in many European medical journals. A recent systematic review found no evidence for antimicrobial or immunomodulatory treatment for this condition.

  • Autoimmune Encephalitis: Not Rare and Increasing

    Detection of autoimmune encephalitis is increasing over time. According to the results from this population-based study, its prevalence and incidence are comparable to infectious encephalitis.

  • Treatment for Autoimmune Small-fiber Neuropathy

    The cause of most cases of small-fiber neuropathy is uncertain, but many patients have accompanying autoimmune biomarkers. In a carefully selected group of such patients, intravenous immunoglobulin treatment appears to provide benefit.